GreenJay Therapeutics, Inc. — Form D
GreenJay Therapeutics, Inc. of HOUSTON, TX, a company, filed a Form D exempt-offering notice with the SEC on 2023-06-16. The offering totals $1.0M, of which $1.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2023-06-16
- Form: D
- Accession: 0001980584-23-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $1.0M
- Amount sold: $1.0M
- Minimum investment: $5K
- Investors: 27
- Date of first sale: 2023-01-25
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-484521
Issuer
- Name: GreenJay Therapeutics, Inc.
- CIK: 0001980584
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 9128 LAKES AT 610 DRIVE, HOUSTON, TX, 77054
- Phone: 8324525117
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Borje Thomas Andersson | Director | Conroe, TX |
| Tommy Thomas Lee | Director | Conroe, TX |
| Michael Thomas Redman | Director | Conroe, TX |
| Michael Thomas Redman | Executive Officer | Conroe, TX |
| Tommy L Lee | Director | Houston, TX |
| Borje S Andersson | Director | Houston, TX |
| Michael T Redman | Director | Houston, TX |
| James Donald Payne | Executive Officer | Houston, TX |
Other filings by this issuer (1)
More